| Outgoing Relation(s) |
| EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor (CHEBI:77402) is a EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD+ or NADP+ as acceptor) inhibitor (CHEBI:76869) |
| Incoming Relation(s) |
| citalopram (CHEBI:3723) has role EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor (CHEBI:77402) |
| clomipramine (CHEBI:47780) has role EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor (CHEBI:77402) |
| ebselen (CHEBI:77543) has role EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor (CHEBI:77402) |
| quinacrine (CHEBI:8711) has role EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor (CHEBI:77402) |
| thioridazine (CHEBI:9566) has role EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor (CHEBI:77402) |
| trifluoperazine (CHEBI:45951) has role EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor (CHEBI:77402) |
| EC 1.8.1.4 (dihydrolipoyl dehydrogenase) inhibitor (CHEBI:134545) is a EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor (CHEBI:77402) |
